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ABSTRACT
Actin is one of the most abundant eukaryotic cytoskeletal polymer-
forming proteins, which, in the filamentous form, regulates a number
of physiological processes, ranging from cell division and migration
to development and tissue function. Actins have different post-
translational modifications (PTMs) in different organisms, including
methionine, alanine, aspartate and glutamate N-acetylation,
N-arginylation and the methylation of the histidine at residue 73
(His-73), with different organisms displaying a distinct signature of
PTMs. Currently, methods are not available to produce actin isoforms
with an organism-specific PTM profile. Here, we report the Pick-ya
actin method, a method to express actin isoforms from any eukaryote
with its own key characteristic PTM pattern. We achieve this using a
synthetic biology strategy in a yeast strain that expresses, one, actin
isoforms with the desired N-end via ubiquitin fusion and, two,
mammalian enzymes that promote acetylation and methylation.
Pick-ya actin should greatly facilitate biochemical, structural and
physiological studies of the actin cytoskeleton and its PTMs.
KEYWORDS: Pichia pastoris, Actin cytoskeleton, Post-translational
modification, Recombinant actin
INTRODUCTION
Actin is a highly conserved eukaryotic cytoskeletal protein, which
polymerizes into double-stranded, dynamic polar filaments that
exhibit continuous polymerization and depolymerization. A variety
of eukaryotes have evolved diverged actin isoforms and orthologues,
which assemble into a variety of molecular machineries executing
mechanical tasks, including cell division and cell migration. How
actins undergo defined molecular structural changes facilitating
polymerization and depolymerization, and how they carry out
distinct functions at different cellular locations and in different
organisms and tissues is not well understood. The understanding of
actin function in different organisms and tissues is further
complicated by the vast array of PTMs, which differ among
different organisms. Some of the known modifications of actin
include: (1) methionine N-acetylation in yeast; (2) alanine
N-acetylation in Arabidopsis thaliana (Bienvenut et al., 2012);
(3) aspartate and glutamate N-acetylation in animals and amoeba,
mediated by the N-acetyl transferase NAA80 (Drazic et al., 2018;
Goris et al., 2018); (4) N-arginylation in mammals (Karakozova
et al., 2006); and (5) His-73 methylation in animals and amoeba,
mediated by the histidine methyl transferase SETD3 (Kwiatkowski
et al., 2018; Wilkinson et al., 2019). Thus, a precise biochemical and
biophysical understanding of actin function in various organisms and
tissues depends on the ability to produce actin isoforms with
organism-specific signature PTMs. The current methods for actin
purification either constitutively introduce aspartate and glutamate
N-acetylation and His-73 methylation (purification from rabbit or
chicken muscle, Sf9-insect cell cultures, Dictyostelium and human
platelets) or do not introduce either of the above-mentioned
modifications (purification from Saccharomyces cerevisiae and
Pichia pastoris) (Hatano et al., 2018; Müller et al., 2013; Noguchi
et al., 2007; Ohki et al., 2009).
Given that recombinant actin expressed in P. pastoris is neither
N-acetylated on aspartate and glutamate residues nor His-73
methylated, we reasoned that further engineering of P. pastoris
may provide a means to express and purify actin isoforms with
distinct organism-specific PTMs. Here, we express NAA80 and
SETD3 either singly or together in P. pastoris. This, combined with
our previously described ubiquitin fusion approach (Hatano et al.,
2018), has led to the development of the Pick-ya actin method,
which facilitates production of actin isoforms with organism-
specific PTM profiles.
RESULTS
Fig. 1 shows key PTMs observed in actin from mammals, yeast and
the plant A. thaliana. Mammalian actin can be isolated with one of
seven different modifications at the N-terminus, which are mediated
by a combination of aminopeptidases, NAA80 acetyl transferase
(Drazic et al., 2018; Goris et al., 2018) and ATE1 arginyl-tRNA-
protein transferase (Karakozova et al., 2006). Furthermore, human
actin is methylated on His-73 by the SETD3 methyl transferase
(Kwiatkowski et al., 2018; Wilkinson et al., 2019). A. thaliana actin
is N-terminally acetylated at alanine and is only weakly (9%)
methylated on His-74, the equivalent residue to mammalian and
yeast His-73 (Wilkinson et al., 2019). Finally, yeast actin is
acetylated on the initiator methionine and is not methylated on His-
73 (Kalhor et al., 1999). We systematically established yeast strains
that introduced one or more of the above-mentioned modifications.
Towards this end, we cloned human NAA80 acetyl transferase and
human SETD3 methyl transferase in P. pastoris expression
plasmids, which are as described in the subsequent sections.
Expression in P. pastoris and purification of N-acetylated
human β and γ actin
Human β- and γ-actin expressed in P. pastoris are not processed at
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and is acetylated by native acetyl transferases (Hatano et al., 2018).
The canonical N-acetylation occurs on an aspartate residue on
β-actin and a glutamate residue on γ-actin. To facilitate generation of
β- and γ-actin with aspartate or glutamate at the N-terminus, we
expressed a DNA molecule (Fig. 2A) encoding a translational
fusion of ubiquitin with the actin gene lacking the initiator
methionine followed by sequences encoding human thymosin β4
(Tβ4) and the eight consecutive histidine amino acid residues
(8His), which facilitates one-step affinity purification using nickel-
NTA resin (Hatano et al., 2018; Huang et al., 2016; Kijima et al.,
2016; Noguchi et al., 2007). In this strain, we introduced an
integrative plasmid vector backbone or a plasmid expressing human
NAA80, which promotes actin N-acetylation. The translational
fusion was purified as described previously using an affinity-
binding approach (Hatano et al., 2018). When the four purified actin
fusions were subjected to mass spectrometry (MS), we found that
the majority of the N-termini in β actin contained an aspartate
residue, whereas a large number of acetylated aspartate (Ac-Asp)-
containing peptides were detected when NAA80 was co-expressed
in these cells (Fig. 2B,D; Fig. S1A). Similarly, the majority of γ-
actin contained a glutamate residue at the N-terminus in control
cells, whereas it contained acetylated glutamate (Ac-Glu) at the
N-terminus when NAA80was co-expressed (Fig. 2C,E). Evaluation
of the number of non-acetylated versus acetylated N-terminal
peptides from β- and γ-actin clearly demonstrated that NAA80
expression strongly promotes the N-terminal acetylation of β- and
γ-actin. Together, we concluded that expression of NAA80 is
sufficient to introduce N-acetylation of human β and γ actin
expressed in P. pastoris.
Expression in P. pastoris and purification of His-73
methylated human β- and γ-actin
We next established a system to prepare His-73-methylated human
β- and γ-actin. Recent work has shown that the mammalian SETD3
methyl-transferase methylates His-73 of human actins, using
S-adenosyl methionine as a methyl group donor (Kwiatkowski
et al., 2018; Wilkinson et al., 2019; Fig. 3A). To promote actin His-
73 methylation, we co-expressed the mammalian SETD3 and β- or
γ-actin in P. pastoris cells. Again, methylated peptides covering
His-73 were detected in cells expressing SETD3, but not in cells
without SETD3 (Fig. 3B–E; Fig. S1B). Both, β- and γ-actin were
methylated on His-73 (Fig. 3B,C). Quantification of the relative
intensity of methylated versus non-methylated peptides revealed a
clear correlation between expression of SETD3 and methylation of
His-73 on β- and γ-actin expressed in P. pastoris (Fig. 3D,E).
These experiments established that human β- and γ-actins can be
efficiently methylated by SETD3 in P. pastoris.
Expression inP. pastorisandpurification ofN-acetylated and
His-73methylated human β-actin, and arginylated andHis-73
methylated γ-actin
Next, we sought to purify dually modified human β-actin with
N-acetylation and His-73 methylation. Towards this goal, we
employed a ubiquitin-fusion strategy as described in Fig. 2A. In P.
pastoris cells expressing the Ub–D-actin-Tβ4–8His fusion, we
expressed NAA80 and SETD3. Actin was purified sequentially by
nickel affinity chromatography, release from Tβ4 and 8His by
chymotrypsin treatment, and a cycle of polymerization and
depolymerization (see Materials and Methods for full details of
the purification). Fig. 4A shows results from a size exclusion
column, in which monomeric actin was obtained in the peak
fractions. Mass spectrometric analysis of the purified actin
confirmed that it was both N-acetylated and His-73 methylated
(Fig. S2), as described in Figs 2 and 3.
Next, we tested whether the purified N-acetylated and His-73
methylated human β-actin was capable of undergoing
polymerization. Towards this goal, we incubated the purified
human actin with a trace amount of S. cerevisiae actin that was
fluorescently labelled by conjugation of Alexa Fluor 488 C5-
maleimide to Cys-374 and compared the elongation rate with human
platelet actin (commercially available from Cytoskeleton, Inc.). In
this experiment, we found that the dually modified recombinant actin
was capable of polymerizationwith comparable elongation rate (∼3.5
subunits/s/µM) to the platelet actin in two independent experiments
(Fig. 4B–D).
While N-acetylation is one key modification of the N-terminus of
actin, a mutually exclusive modification termed arginylation also
occurs on human β-actin. We have shown that the ubiquitin fusion
strategy can be used to express and purify arginylated human β-actin
from P. pastoris (Hatano et al., 2018). To develop a full actin toolkit,
we sought to express and purify arginylated and methylated actin.
To this end, we co-expressed the Ub–R-actin–Tβ4–8His fusion and
SETD3 in P. pastoris. We were able to purify arginylated and His-
73 methylated actin at levels comparable to N-acetylated and His-73
methylated actin (Fig. 4E; Fig. S3).
Collectively, these experiments show that the system we have
developed can allow a mix and match strategy to purify actin
as (1) unmodified, (2) N-acetylated and unmethylated, (3)
Fig. 1. Post-translational modification
of actin. Divergent post-translational
modifications on actin. Shown are
N-terminal peptide sequences of nine actins
(six fromH. sapiens, one from S. cerevisiae,
and three from A. thaliana), and the
observed modifications at the N-terminus.
The right column summarizes whether
His-73 methylation is observed in these
organisms.
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Fig. 2. See next page for legend.
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N-acetylated and methylated, (4) arginylated and unmethylated, and
(5) arginylated and unmethylated forms.
Expression in P. pastoris and purification of alanine
N-acetylated and His-73 methylated A. thaliana actin
We next wanted to extend the utility of the approach we have
developed to purify actin isoforms. We were in particular interested
to use our system to express plant actin isoforms since they have
unique profiles of PTMs (Fig. 1). Actins from the model plant
A. thaliana have been shown, through proteomic analysis, to be
N-acetylated on alanine (rather than aspartate or gluatamate, as seen
in mammalian actins), and methylation of His-74 is only found in
∼9% of the cellular pool of actin (Bienvenut et al., 2012; Wilkinson
et al., 2019). We reasoned that the P. pastoris expression system
might offer a better avenue to producing plant actins due to our
ability to control each of the modifications.We generated a fusion of
the A. thaliana Actin-2 (Act2) gene, in which we again used the
ubiquitin fusion strategy, to allow exposure of the alanine residue at
position 2 at the N-terminus (Fig. 5A). A Ub–A-actin–Tβ4–8His
fusion was expressed in P. pastoris. We found, through MS, that the
exposed N-terminal alanine residuewas acetylated by a native acetyl
transferase (Fig. 5B; Fig. S1C). This observation established that
A. thaliana actin can be expressed in P. pastoris in a N-acetylated
form for biochemical studies.
Since ∼9% of A. thaliana actin is methylated on His-74
(corresponding to His-73 in animal actin), we desired to establish
a system to purify His-74 methylated actin (Wilkinson et al., 2019).
To this end, we expressed SETD3 in P. pastoris expressing Ub–A-
actin–Tβ4–8His. MS confirmed that the A. thaliana actin was
methylated on His-74 (Fig. 5C,D; Fig. S1C). Comparison of the
relative intensity profiles of methylated and non-methylated
peptides revealed a clear correlation between SETD3 expression
and His-74 methylation (Fig. 5D). This work established that
A. thaliana actin can be expressed in an alanine N-acetylated form
with or without His-74 methylation.
Finally, we tested whether the purified alanine N-acetylated
A. thaliana actin was capable of polymerization in vitro. We
performed a similar experiment to that with the human β-actin
described in Fig. 4B–D, and found that A. thaliana actin
polymerized at ∼3–4 monomers/s/µM in two independent
experiments (Fig. 5E). This finding established that A. thaliana
actin purified from P. pastoris was functional in vitro (Fig. S4).
DISCUSSION
In this study, we have substantially improved upon our previous
work (Hatano et al., 2018) on expression and purification of
heterologous actin isoforms in P. pastoris. Importantly, we
have developed approaches to precisely control the N-acetylation
and His-73 methylation status of expressed heterologous actin
forms. As previously reported, the yield of the actin was ∼0.5 mg
from 1 l yeast culture in our set up using standard glass flasks for the
yeast culture (Hatano et al., 2018). The yield could be further
improved by using high-aeration culture, which can achieve high-
density cultivation of the yeast. We see two major advantages for
this system we describe, which we term as Pick-ya actin.
First, Pick-ya actin will facilitate biochemical and structural
studies of actin isoforms, and their modifications. We imagine that
any laboratory investigating the role of each of the modifications of
mammalian β- and γ-actin on its structural, biochemical and
biophysical properties could now work with pure actin isoforms
with the desired modifications. Actin without modifications can
be readily isolated without the need for cell lines lacking NAA80
or SETD3, and actins with modifications can be purified upon
co-expression of the appropriate enzymes.
Second, and perhaps more importantly, Pick-ya actin could help
experimenters understand the diversity of actin function in a variety
of different organisms with different profiles of N-acetylation and
His-73 methylation. In this regard, Pick-ya actin may be preferable
to the Sf9 insect cell culture-based approach. This is due to the
fact that wild-type P. pastoris cells do not appreciably post-
translationally modify heterologous actins either by N-acetylation
or His-73 methylation, whereas Sf9 cells do. The ability to express
unmodified actin, yet promote N-acetylation or His-73 methylation
by expression of appropriate enzymes, as and when required, offers
the potential to generate the correct actin isoform with the
appropriate PTMs for biochemical, biophysical and structural
studies. For example, study of A. thaliana actin in vitro could
employ a mixture of alanine acetylated actin with a fraction (∼10%)
that is His-73 methylated and the rest unmethylated. In this regard,
we believe Pick-ya actin will facilitate the study of actins from a
large variety of eukaryotes, including plants. Given that methods are
not available to purify actin isoforms from native sources presently,
it will be important to compare the performance of Pick-ya actin
isoforms with actin isoforms purified from native sources at such a
time when such methods are developed.
A simple flow chart for actin expression and purification requires
establishing (1) whether actin isolated from the source contains
N-methionine, alanine, glutamate or aspartate N-acetylation,
(2) whether His-73 is methylated and (3) whether the C-terminal
amino acid is a phenylalanine. Based on the answers to these
questions, expression of appropriate ubiquitin–actin–Tβ4–8His
fusion proteins with or without NAA80 and SETD3 and




Plasmids and strains used in this study are listed in Tables S1 and S2,
respectively.
pPICZc-actin-thymosin β4-8His
Actin-coding sequences codon-optimized for expression in P. pastoris
were synthesized by gBlocks (IDT) and cloned into pPICZc (Invitrogen),
which adds, at the C-terminus, an in-frame chymotrypsin cleavage site,
linker sequence, thymosin β4 and a His tag (Noguchi et al., 2007; Hatano
et al., 2018).
N-terminal ubiquitin fusion constructs
The 5′ portion of the S. cerevisiae UBI4 gene encoding ubiquitin repeat 1
(encoding amino acids 1–76) were PCR amplified from genomic DNA isolated
from S. cerevisiae and cloned at the 5′ end of in-frame actin in pPICZc-actin-
thymosin β4-8His plasmid linearized by EcoRI using Gibson assembly. The
first ATG for actin was removed as part of the cloning.
Fig. 2. N-acetylation of recombinant human β- and γ-actin. (A) Schematic
representation of purification of synthetically N-acetylated human β- and γ-actin.
A ubiquitin (Ub) moiety was fused at the N-terminus of actin lacking the first
methionine residue. The Ub tag is removed by the endogenousUb protease and
the exposed N-terminal aspartate residue in β-actin or glutamate residue in γ-
actin is acetylated by theNAA80 enzyme. TheC-terminal tag is then removed by
chymotrypsin treatment to liberatemodified full-length actin. (B,C) MS spectra of
the N-terminal peptide derived from recombinant β-actin (B) and γ-actin (C).
(D,E) Label-free quantification of acetylated or unmodified N-terminal peptide in
β- and γ-actin. The bar graphs shows mean±s.e.m. from three independent
experiments. The relative intensity of N-acetylated peptide in control sample and
the sample expressing NAA80 is shown; (D) β actin, (E) γ-actin.
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NAA80 and SETD3 genes
NAA80 andMyc-SETD3 genes codon-optimized for expression in P. pastoris
were synthesized by gBlocks (IDT) and cloned into pIB2 (PGAP promoter) or
pIB4 (PAOX1 promoter) P. pastoris expression vectors by Gibson assembly.
Dual expression of NAA80 and myc-SETD3
A PCR-amplified PGAP:NAA80::TAOX1 DNA fragment was cloned at the
3′ end of the NAA80 gene. The resulting plasmid lacking the terminator for
Fig. 3. Methylation of the residue His-73 in human β- and γ-actin. (A) Enzymatic reaction catalysed by the SETD3 methyl transferase. The peptide sequence
from human non-muscle actin around the amino acid residues 66–81 are shown. SETD3 recognizes the peptide surrounding His-73 in actin and transfers a
methyl group from S-adenosyl methionine (SAM) to the histidine residue to generate methylated actin and S-adenosyl homocysteine (SAH). (B,C) MS spectra of
the peptide from recombinant actin carrying methylation at His-73. (B) β actin, (C) γ-actin. (D,E) Label-free quantification of methylated or unmodified His-73
Peptide in β- and γ-actin. The bar graph shows mean±s.e.m. from three independent experiments. The relative intensity of methylated peptide in control sample
and the sample expressing SETD3 is shown; (D) β actin, (E) γ-actin.
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the NAA80 gene was linearized by PstI/SphI digestion and CYC1 terminator
was cloned by ligation.
P. pastoris culture
The composition of the minimal glycerol (MGY) and minimal methanol
(MM) growth media, and basic techniques for P. pastoris are described in
the Pichia Expression Kit Instruction Manual (https://www.thermofisher.
com/order/catalog/product/V19020).
P. pastoris transformation
Plasmid DNA was linearized, and yeast cells were transformed by using the
lithium chloride method or electroporation. Transformants with the pPICZc
plasmid were selected on yeast extract peptone dextrose (YPD) solid medium
containing 100 mg/l Zeocin (Gibco, #R25001). For transformation of cells
with pIB2 or pIB4 plasmids, his4 cells were used as the host, and transformants
were selected onMGY. Single colonies were picked and cultured onYPD solid
medium, and the transformants were re-selected to select stable clones.
Fig. 4. Purification of dually modified human β-actin.
(A) Size-exclusion chromatography (Sephacryl S-100HR)
showing homogenous G-actin purified from P. pastoris
expressing NAA80 and SETD3. (B) Time-lapse images
showing actin polymerization. Actin was visualized by
means of incorporation of 20% S. cerevisiae (Sc)Act1
conjugated to Alexa Fluor 488. F-actin was tethered on the
coverslip surface through the use of 0.5% ScAct1 with
biotin–PEG2. (C) Kymograph (right) showing elongation of
a single actin filament. (D) Elongation rate of recombinant
and native (human platelet) actin. Elongation rate (subunit/
second/µM) at the barbed end of actin was quantified as
described in the Materials and Methods. Data from two
independent experiments (n=12) for each actin are shown
in the figure as a violin plot. Welch’s t-test showed
significant difference between elongation rate of
‘Recombinant’ and ‘Native’ actin (exp1: *P=0.025; exp2:
**P=0.0096). Mean±s.d. values are given above each plot.
(E) SDS-PAGE gel of purified arginylated β-actin (Arg-
actin) carryingmethylation at His-73. N-acetylated and His-
73 methylated β-actin is also shown in this gel.
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Fig. 5. See next page for legend.
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Purification of recombinant actin from P. pastoris
Actin was purified as described previously (Hatano et al., 2018) with slight
modifications. P. pastoris transformants were inoculated into MGY liquid
medium and cultured at 30°C, with shaking at 220 rpm. The culture medium
was diluted and cells were further cultured at 30°C, with rotation at 220 rpm,
until the optical density at 600 nm (OD600) reached ∼1–1.5. Cells were
pelleted by centrifugation at 10,628 g at 25°C for 10 min (Thermo Fisher
Scientific, #F9-6×1000 LEX rotor) and washed once with sterilized water
prior to re-suspension into MM medium. Cells were cultured in 2 l baffled
flasks (500 ml culture each) at 30°C, with rotation at 220 rpm, for 1.5–
2 days; 0.5% methanol was added every 24 h of culturing. Cells were
washed once with water and resuspended in water. The suspension was
dripped into liquid nitrogen to freeze and stored at −80°C until use.
Frozen cells were loaded into a grinder tube (maximum 50 g of sample,
#6801, SPEX® SamplePrep) pre-cooled with dry ice and ground in a Freezer
mill (#6870, SPEX® SamplePrep) in a liquid nitrogen bath. The duration of
the grinding was 1 min with 14 cycles per second (cps). The grinding was
repeated 40 times at 1 min intervals. Liquid nitrogen was re-filled every 10
cycles of the grinding. The lysate powder was stored at −80°C until further
use. The lysate was resolved in an equal amount of 2× binding buffer
[20 mM imidazole, 20 mM HEPES pH 7.4, 600 mM NaCl, 4 mM MgCl2,
2 mM ATP, 2× concentration of protease inhibitor cocktail (cOmplete,
EDTA free #05056489001, Roche), 1 mM phenylmethylsulfonyl fluoride
(PMSF) and 7 mM β-mercaptoethanol (β-ME)]. The lysate was sonicated on
ice (10 s with 60% amplitude, Qsonica Sonicators) until all aggregates were
resolved. The lysate was centrifuged at 4°C at 3220 g for 15 min (Eppendorf
#A-4-81 rotor) to remove intact cells and debris, then further cleared by
centrifugation at 4°C and 25,658 g for 1 h (Thermo Fisher Scientific, #A23-
6×100 rotor). The supernatant was passed through a 0.22 µm filter (Corning
#431097) and incubated with nickel resin (Thermo Fisher Scientific,
#88222) at 4°C for 1–1.5 h. The resin was pelleted by centrifugation at 4°C
at 1258 g for 5 min (Eppendorf #A-4-81 rotor) and washed with 25 ml ice-
cold binding buffer [10 mM imidazole, 10 mM HEPES pH 7.4, 300 mM
NaCl, 2 mM MgCl2, 1 mM ATP, protease inhibitor cocktail (cOmplete,
EDTA free #05056489001, Roche), 1 mM PMSF and 7 mM β-ME]. The
resin was loaded into an open column (Bio-Rad, #731-1550) and washed
first with ice-cold 20 ml binding buffer, then with 45 ml ice-cold G-buffer
[5 mM HEPES pH 7.4, 0.2 mM CaCl2, 0.01% (w/v) NaN3, 0.2 mM ATP
and 0.5 mM dithiothreitol (DTT)]. The resin was resuspended in 6 ml ice-
cold G-buffer containing 5 µg/ml TLCK-treated chymotrypsin (Sigma,
#C3142) and incubated overnight at 4°C. The chymotrypsin was inactivated
by addition of PMSF to 1 mM and incubated for 30 min on ice. The eluate
was then collected into a tube. Actin retained on the resin was eluted with
G-buffer and all the elution fractions were combined. The eluate was
concentrated using a 30 kDa cut-off membrane (Sigma-Aldrich, #Z677892-
24EA) and the final volume adjusted to 900 µl with ice-cold G-buffer. Actin
was polymerized by addition of 100 µl 10× MEK solution [20 mM MgCl2,
50 mM glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic (EGTA) and
1 M KCl] for 1 h at room temperature. F-actin was pelleted by
ultracentrifugation for 1 h at room temperature at 45,000 rpm (Beckman
TLA-55 rotor) and re-suspended in ice cold G-buffer. F-actin was
depolymerized by dialysis against 1 l G-buffer at 4°C for 2 days. Dialysis
buffer was exchanged every morning and evening (a total of three times).
Any remaining F-actin was pelleted by ultracentrifugation at room
temperature at 45,000 rpm for 30 min (Beckman TLA-55 rotor). Then,
actin in the supernatant was loaded into HiPrep 16/60 Sephacryl S-100 HR
(GE Healthcare, #17116501) pre-equilibrated with G-buffer for a size-
exclusion chromatography (SEC). The concentration of actin was
determined by measuring the absorbance at 290 nm [A290=0.63 (/mg/ml/
cm)] using a NanoDrop 2000c spectrophotometer (Thermo Fisher
Scientific).
S. cerevisiae Act1 labelling with Alexa Fluor 488–maleimide
or biotin–PEG2–maleimide
S. cerevisiae Act1 was expressed and purified as described above until the
digestion with chymotrypsin. After the digestion and inactivation of
chymotrypsin by PMSF treatment, the eluate was collected and actin
retained on the resin was also eluted with G-buffer without DTT. All the
eluates were pooled in a tube and concentrated to 2.5 ml using a 30 kDa cut-
off membrane (Sigma-Aldrich, #Z677892-24EA). The buffer was
exchanged using a PD-10 desalting column with Sephadex G-25 resin
(GE-Healthcare, #17085101) pre-equilibrated with G-buffer without DTT.
The concentration of actin was adjusted to ∼25 µM and polymerized by
addition of 100 mM KCl and 2 mM MgCl2. After 1 h at 4°C, actin was
incubated with 3–5 molar excess amount of Alexa Fluor 488 C5 maleimide
(Invitrogen, #A10254) or EZ-Link Maleimide-PEG2-Biotin (Invitrogen,
#A39261) for 1 h at room temperature. The cysteine–maleimide reaction
was quenched by addition of 10 mM DTT to the sample and F-actin was
pelleted and re-suspended in G-buffer as described above. Monomeric
G-actin was obtained by depolymerization and SEC as described above. The
concentration of Alexa Fluor 488-labelled actin was measured by
determining the absorbance at 290 nm (actin) and 495 nm (A495; Alexa
Fluor 488) on a NanoDrop 2000c spectrophotometer (Thermo Fisher
Scientific), and calculated using the following formula: actin concentration
(M)=A290/(0.63×42,000). The extinction coefficient of Alexa Fluor 488 at
495 nm is 72,000 M−1 cm−1, with a correction factor for Alexa Fluor 488
absorbance at 290 nm of 0.138. Labelling efficiency was calculated as
follows: (A495/72,000)/actin concentration (M). The concentration of
biotin–PEG2–labelled actin was calculated by SDS-PAGE and
Coomassie Brilliant Blue (CBB) staining using purified actin as the
standard.
Cover glass preparation for TIRF microscopy
A microscope cover glass (24×60 mm) was cleaned with 2% Helmanex II
(Hellma, #9-307-011-4507) for 1 h, followed by 3 M NaOH for 30 min in a
60°C water bath sonicator. Cleaned cover glass was rinsed with pure water
and dried with nitrogen gas. The cover glass was adhering to sticky-Slide VI
0.4 (ibidi, #80608) to make six-well flow chambers. The chamber was
passivated with the PLL-g-PEG and PEG–biotin mix [4 mg/ml PLL-g-PEG
and 0.05 mg/ml PLL-PEG–biotin (20%)] for 30 min at room temperature.
The chamber was washed with G-buffer without ATP and DTT (G-AD
buffer) prior to blocking with 1% BSA in G-AD buffer. The chamber was
then washed with G-AD buffer prior to incubation with 0.1 mg/ml avidin in
G-AD buffer for 15 min at room temperature. The chamber was washed with
G-AD buffer, followed by TIRF buffer [10 mM imidazole pH 7.4, 50 mM
KCl, 1 mMMgCl2, 1 mM EGTA, 0.2 mMATP (pH 7), 10 mMDTT, 0.5%
methylcellulose (4000 cP) and 15 mM glucose].
Actin polymerization assay with TIRF microscopy
20 µM actin consists of∼80% target actin, 20%Alexa Fluor 488-conjugated
Act1 and 0.25% biotin–PEG2–Act1 were ultracentrifuged at ∼25 psi with
Airfuge for 10 min at room temperature (Beckman A-110 rotor at
160,000 g). The top 75% (supernatant) fraction was collected as the
sample. Actin was diluted to 1.5 µM in TIRF buffer containing 12 kU/ml
catalase and 48 kU/ml glucose oxidase to start its polymerization.
TIRF microscopy settings and image acquisition
For total internal reflection fluorescence (TIRF) microscopy, an Andor
Revolution TIRF system was equipped with the inverted Nikon Eclipse
Fig. 5. A. thaliana Actin-2 with appropriate PTMs. (A) Schematic
representation of purification of A. thaliana actin. A Ub moiety was fused at the
N-terminus of actin lacking the first Met. The Ub tag is removed by the
endogenous Ub protease and the exposed N-terminal alanine residue is
N-acetylated by a native acetyl transferase. The C-terminal tag is then removed
by chymotrypsin treatment to liberate modified full-length actin. (B) MS spectra
of acetylated peptides in recombinant A. thaliana Actin-2. (C) Methylation at
His-74 in A. thaliana Actin-2 in the presence of SETD3. (D) Label-free
quantification of methylated and unmodified His-73 peptide in A. thaliana (At)
actin. Two independent experiments (exp1 and exp2) were performed.
The relative intensity of methylated peptide in control sample and the sample
expressing SETD3 is shown. (E) Elongation rate of recombinant A. thaliana
Actin-2. Elongation rate (subunit/second/µM) of recombinant A. thaliana
Actin-2 at the barbed end of actin was quantified as described in Fig. 4D and
Materials and Methods. The results of two independent experiments (n=31)
are shown in the figure as mean±s.d.
8













microscope base, Nikon Apo 100×/1.49 NA Apo TIRF objective lens,
Nikon TIRF module, a 60 mW 488 nm solid state laser and an Andor Zyla
sCMOS camera. Images were acquired at 65 nm/pixel. The TIRF
microscopy was performed at room temperature. Images were acquired
with a 2 s interval.
Data analysis
The acquired images were analysed with the open source software ImageJ.
Individual F-actin filaments were traced by line segment tools and their
kymographs were generated with the Kymograph builder plug-in. Actin
elongation rate was calculated from the angle of the kymograph slopes and
the data was processed and analysed by Python3 libraries pandas and
numpy. The graph for Figs 4D and 5E were generated with the Python3
library seaborn and matplotlib, respectively. Statistical analysis for Fig. 4D
was performed by using the Python3 library SciPy.
Mass spectrometric analysis
For MS, protein was reduced using 10 mM DTT (#MB1015, Melford) for
60 min at room temperature. The sample was then alkylated with 55 mM
iodoacetamide (#I6709, Sigma) for 20 min in the dark at room temperature
and digested using 1 μg trypsin (sequencing grade; #V5111, Promega) per
100 μg of protein overnight at 37°C. Then, 20 μl samples were analysed by
nano-liquid chromatography-electrospray ionization-tandem MS (LC-ESI-
MS/MS) using UltiMate® 3000 HPLC series using the Nano Series™
Standard Columns for separation. A linear gradient from 4% to 25% solvent
B (0.1% formic acid in acetonitrile) was applied over 30 min, followed by a
step change 25–35% solvent B for 10 min, followed by a 3 min wash of 90%
solvent B. Peptides were directly eluted (∼250 nl/min) via a Triversa
Nanomate nanospray source into a Orbitrap Fusion mass spectrometer
(Thermo Scientific). Positive ion survey scans of peptide precursors from
375 to 1575 m/z were performed at 120 K resolution (at 200 m/z) with
automatic gain control 2×105. Precursor ions with charge state 2–6 were
isolated and subjected to higher-energy collisional dissociation (HCD)
fragmentation in the IonTrap at 120 K. MS/MS analysis was performed
using collision energy of 33%, automatic gain control 5×103 and max
injection time of 150 ms. The dynamic exclusion duration was set to 25 s
with a 10 ppm tolerance for the selected precursor and its isotopes.
Monoisotopic precursor selection was turned on. Label-free quantification
(LFQ) of modified precursor ions and unmodified peptides was performed
using MaxQuant (v1.5.5.1). The LFQmodule calculates the integrated peak
area of the precursor ion based on a retention timewindow of 5 min and ppm
error window of 10 ppm to quantify the presence and absence of a precursor
ion of interest in different MS output files. LFQ intensity data for each
sample were normalized to top three unmodified actin peptides. Data was
analysed in triplicate.
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